Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Pozycja w akcjach #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Cena akcji
$0.00695
Ostatnia synchronizacja: 2024-10-29
Kapitalizacja rynkowa
$536.40
Zmiana (1 dzień)
-0.71%
Zmiana (1 rok)
0.00%
Kraj
US
Handel BIOLASE, Inc. (BIOL)

Kategoria

Marża operacyjna dla BIOLASE, Inc. (BIOL)
Marża operacyjna na dzień August 2026 TTM: -36.48%
Według najnowszych raportów finansowych i ceny akcji BIOLASE, Inc., bieżąca marża operacyjna (TTM) wynosi -36.48%. Na koniec 2022 wynosiła -52.28%.
Historia marży operacyjnej dla BIOLASE, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) -36.48% 0.00%
2023 -36.48% -30.22%
2022 -52.28% 27.14%
2021 -41.12% -49.47%
2020 -81.37% 96.88%
2019 -41.33% -8.66%
2018 -45.25% 17.72%
2017 -38.44% 33.10%
2016 -28.88% -29.70%
2015 -41.08% 9.11%
2014 -37.65% 93.18%
2013 -19.49% 341.95%
2012 -4.41% -46.22%
2011 -8.20% -81.29%
2010 -43.83% 541.73%
2009 -6.83% -49.74%
2008 -13.59% 1.34%
2007 -13.41% 93.23%
2006 -6.94% -74.67%
2005 -27.40% 77.58%
2004 -15.43% -201.78%
2003 15.16% 78.35%
2002 8.50% -518.72%
2001 -2.03% -94.60%
2000 -37.62% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
17.03% -100.47%
US
22.03% -100.60%
US
17.86% -100.49%
IE
21.46% -100.59%
US
28.09% -100.77%
US
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.